MILOOP LENS FRAGMENTATION DEVICE FG-11881

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2019-05-17 for MILOOP LENS FRAGMENTATION DEVICE FG-11881 manufactured by Carl Zeiss Meditec Cataract Technology, Inc..

Event Text Entries

[145411871] The device was discarded by the user facility and is not available for evaluation. The device history records were reviewed for this manufacturing lot and there were no discrepancies or unusual findings that relate to the reported event. Based on the information reviewed, the event was attributed to use error and there is no evidence to indicate the presence of a potential quality issue with respect to manufacturing, design, or labeling. Capsular bag damage and dropped nuclear fragments are inherent risks of cataract surgery [reference: schaal s, nesmith blw, ihnen ma, al-latayfeh m. Current medical and surgical management of retained lens fragments after cataract extraction. Us ophthalmic review 2014; 7 (2): 95-99]. Manufacturer's reference #: (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[145411872] A patient underwent cataract surgery in the right eye on (b)(6) 2019 where the miloop was used to section the cataractous lens into fragments. After the first lens sectioning with the miloop, the surgeon had difficulty rotating the lens so company personnel suggested to the surgeon that one cut was sufficient and recommended not proceeding with a second cut. However, the surgeon elected to perform a second cut and inadvertently inserted the miloop too far posteriorly with the tip of the housing tube beyond the center of the capsule and the posterior capsule subsequently ruptured. Half of the lens dislocated into the vitreous and the other half was removed with anterior vitrectomy. A three-piece intraocular lens was implanted uneventfully and the patient was referred to a retina specialist to retrieve the lens fragment. Additional information was requested from the surgeon, who reports that retinal surgery was performed on (b)(6) 2019. The patient's initial postoperative best corrected visual acuity (bcva) was 20/40, improving to 20/30 at last examination on (b)(6) 2019.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3012123033-2019-00005
MDR Report Key8620833
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2019-05-17
Date of Report2019-05-17
Date of Event2019-04-22
Date Mfgr Received2019-04-22
Device Manufacturer Date2018-05-23
Date Added to Maude2019-05-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJANE DEMKOVICH
Manufacturer Street8748 TECHNOLOGY WAY
Manufacturer CityRENO NV 89521
Manufacturer CountryUS
Manufacturer Postal89521
Manufacturer Phone7754731014
Manufacturer G1CARL ZEISS MEDITEC CATARACT TECHNOLOGY, INC.
Manufacturer Street8748 TECHNOLOGY WAY
Manufacturer CityRENO NV 89521
Manufacturer CountryUS
Manufacturer Postal Code89521
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameMILOOP LENS FRAGMENTATION DEVICE
Generic NameOPHTHALMIC HOOK
Product CodeHNQ
Date Received2019-05-17
Model NumberFG-11881
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerCARL ZEISS MEDITEC CATARACT TECHNOLOGY, INC.
Manufacturer Address8748 TECHNOLOGY WAY RENO NV 89521 US 89521


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2019-05-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.